天然产物/人参皂苷Rc,98.4%
产品编号:西域质检-TM25546| CAS NO:11021-14-0| 分子式:C53H90O22| 分子量:1079.269
Ginsenoside Rc 是主要的人参皂甙之一,Ginsenoside Rc 增强 GABA 受体 A (GABAA) 介导的离子通道 (IGABA)。 Ginsenoside Rc 还抑制 TNF-α 和 IL-1β 表达。
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,
天然产物/人参皂苷Rc
This certificate is designed in accordance with ISO 17034 and ISO Guide 31. This reference material (RM) was designed,produced and verified in accordance with ISO/IEC 17025, ISO 17034 and a registered quality management system ISO 9001.
(白色固体)__
冷藏(2~8)℃,置于阴凉处

The certified value(s) and uncertainty(ies) are determined in accordance with ISO 17034 with an 95% confidence level(k=2). Uncertainty is based on the Total Combined Uncertainty, including uncertainties of characterisation, homogeneity and stability testing. Stability values are based on real evidence opposed to simulation.
The balances used for gravimetric measurements are calibrated with weights traceable to the national standards. The calibration of the balances is verified annually by an external accredited calibration service. This analysis method has been verified using an approach consistent with ISO 17034:2016 & ISO 17025:2017.
CERTIFICATE ON | QC SIGNATURE | |
2023-Mar-01 |
![]() |
RM Release |
HPLC
HPLC
This RM is intended for use in a laboratory as a calibration and quality control standard or in method development for analytical techniques.
This reference material meets the specification stated in this certificate until the expiry date, provided it is stored unopened at the recommended temperature here in. If storage after opening is necessary, the RM should be tightly closed and kept from light and moisture.
Read Material Safety Data Sheet (MSDS) and understand any potential hazard(s) prior to the use of this product. All chemicals should be considered potentially hazardous in nature and should only be handled by qualified personnel using established good laboratory practices.
Random replicate samples of the final packaged RM have been analysed to prove homogeneity compliant with ISO 17034.
It is recommended to use 1 mg as the minimum sample size and if less material is used, to increase the certified uncertainty by a factor of two for half sample and four for a quarter of sample.Visit the support section of our website technology videos and frequently asked questions.
相关文档
化学品安全说明书(MSDS)
下载MSDS质检证书(COA)
相关产品
符号 |
![]() GHS07 |
---|---|
信号词 | Warning |
危害声明 | H302-H312-H332 |
警示性声明 | P280 |
个人防护装备 | dust mask type N95 (US);Eyeshields;Gloves |
危害码 (欧洲) | Xn:Harmful; |
风险声明 (欧洲) | R20/21/22 |
安全声明 (欧洲) | S26-S36 |
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 3 |
RTECS号 | LY9536300 |
产品名: | Ginsenoside-Rc |
CAS号: | 11021-14-0 |
制造商/供应商: | 西域试剂 网站:www.hzbp.cn 邮件:13911702513@139.com |
2. 合成/成分数据
产品名: | Ginsenoside-Rc |
别名: | Panaxoside Rc |
分子式: | C53H90O22 |
分子量: | 1079.27 |
3. 急救措施
吸入后: | 如果吸入,移至空气新鲜处,如果呼吸困难,给输氧,如呼吸停止,给予人工呼吸。 |
皮肤接触后: | 用大量的水冲洗,移除污染的衣服和鞋子。 |
眼睛接触后: | 检查并取下隐形眼镜,并用大量的水冲洗;呼叫医生。 |
吞食后: | 如果吞食,用大量纯净水漱口;呼叫医生。 |
4. 消防措施
适当的灭火剂: | 雾状水,二氧化碳,干粉或泡沫。 |
防护设备: | 穿戴自给式呼吸器和防护服,以防止与皮肤和眼睛接触。 |
5. 泄漏应急处理
安全防范措施: | 封锁泄漏区域;穿戴自给式呼吸器,防护服和厚橡胶手套。 |
清洁/收集措施: | 使用液体粘合原料(硅藻土,通用粘合剂)吸取精细粉末; 使用酒精擦洗表面和设备除去污渍; 根据第11条处理被污染的材料。 |
6. 处理和储存
安全处理说明: | 避免吸入和接触皮肤,眼睛及衣物;材料可能略微具有刺激性。 |
储存: |
粉末型式 -20°C 3年;4°C 2年 溶于溶剂 -80°C 6个月;-20°C 1个月 |
7. 接触控制和个人防护
呼吸设备: | NIOSH / MSHA认可的呼吸器。 |
双手保护: | 耐化学腐蚀的橡胶手套。 |
眼睛防护: | 化学安全护目镜。 |
8. 稳定性和反应活性
稳定性: | 按照说明存储是稳定的;避免强氧化剂。 |
热分解/其他要避免的情况: | 避免光和热。 |
9. 毒性资料
急性毒性: | 无可用资料。 |
主要刺激性影响: | 无可用资料。 |
在皮肤上: | 无可用资料。 |
对眼睛: | 无可用资料;可能具有刺激性。 |
10. 生态资料
一般注意事项: | 无可用资料。 |
11. 废弃处置
按照所在国家,省份,县市和地方的法规处置。 |
12. 运输信息
正确的运输名称: | 无 |
非危险品运输: | 这种物质被视为非危险品运输。 |
13. 法规信息
尚未有针对此产品作出的化学安全性评估。 |
14. 其他信息
这种化学品仅供受过训练的,有经验的研究人员在穿戴适当装备和授权允许的情况下进行操作处理。以上信息基于我们目前的知识被认为是正确的,但只适用于作为有经验人员的指导。请咨询您自己的安全顾问,并遵守当地和国家的安全法规。在任何其他没有被警告的情况下,并不意味着绝对没有危险存在。西域生物技术不承担任何使用这种化学品所造成的损害和责任。2023 西域生物技术版权所有。 |
~% ![]() 11021-14-0 |
文献:Kitagawa; Taniyama; Yoshikawa; Ikenishi; Nakagawa Chemical and Pharmaceutical Bulletin, 1989 , vol. 37, # 11 p. 2961 - 2970 |
~% ![]() 11021-14-0 |
文献:Chemical and Pharmaceutical Bulletin, , vol. 37, # 11 p. 2961 - 2970 |
上游产品 1 | |
---|---|
下游产品 0 |
- 38. Wang, Xiaoping, et al. "Baoyuan decoction ameliorates apoptosis via AT1-CARP signaling pathway in H9C2 cells and heart failure post-acute myocardial infarction rats." Journal of ethnopharmacology 252 (2020): 112536.https://doi.org/10.1016/j.jep.2019.112536
- 37. Joo, Kyung-Mi, et al. "Pharmacokinetic study of ginsenoside Re with pure ginsenoside Re and ginseng berry extracts in mouse using ultra performance liquid chromatography/mass spectrometric method." Journal of pharmaceutical and biomedical analysis 51.1 (20
- 36. Yongshen Ren, Jiao Ai, Xinqiao Liu, Shuai Liang, Yao Zheng, Xin Deng, Yan Li, Jing Wang, Xukun Deng, Lin-Lin Chen, Anticoagulant active ingredients identification of total saponin extraction of different Panax medicinal plants based on grey relational anal
- 35. Chen, Jiali, et al. "Ginsenosides and amino acids in flavored ginseng chips as affected by food formulation and processing technology." LWT-Food Science and Technology 62.1 (2015): 517-524.https://doi.org/10.1016/j.lwt.2014.10.047
- 34. Hong Zhang, Jia-Ming Jiang, Dan Zheng, Ming Yuan, Zhi-Ying Wang, Hong-Mei Zhang, Chang-Wu Zheng, Lian-Bo Xiao, Hong-Xi Xu, A multidimensional analytical approach based on time-decoupled online comprehensive two-dimensional liquid chromatography coupled wit
- 33. Hong Zhang, Jia-Ming Jiang, Dan Zheng, Ming Yuan, Zhi-Ying Wang, Hong-Mei Zhang, Chang-Wu Zheng, Lian-Bo Xiao, Hong-Xi Xu, A multidimensional analytical approach based on time-decoupled online comprehensive two-dimensional liquid chromatography coupled wit
- 32. Hong Zhang, Jia-Ming Jiang, Dan Zheng, Ming Yuan, Zhi-Ying Wang, Hong-Mei Zhang, Chang-Wu Zheng, Lian-Bo Xiao, Hong-Xi Xu, A multidimensional analytical approach based on time-decoupled online comprehensive two-dimensional liquid chromatography coupled wit
- 31. Jin, Wenqi, et al. "Ginsenoside Rd attenuates ACTH-induced corticosterone secretion by blocking the MC2R-cAMP/PKA/CREB pathway in Y1 mouse adrenocortical cells." Life sciences 245 (2020): 117337.https://doi.org/10.1016/j.lfs.2020.117337
- 30. Yu, Jingping, et al. "Comprehensive Quality Evaluation of American Ginseng for Different Parts and Abnormal Trait Based on the Major Ginsenoside Contents and Morphological Characteristics." BioMed research international 2021 (2021).https://doi.org/10.1155/
- 29. Zhang, Hong-Mei, et al. "Holistic quality evaluation of commercial white and red ginseng using a UPLC-QTOF-MS/MS-based metabolomics approach." Journal of pharmaceutical and biomedical analysis 62 (2012): 258-273.https://doi.org/10.1016/j.jpba.2012.01.010
- 28. Zhengming Qian, Qi Huang, Chunhong Li, Jing Chen, Gang Li, Hongyan Ma & Juying Xie (2020) Analysis of ginseng root and leaf by multiple columns and detections liquid chromatography, Journal of Liquid Chromatography & Related Technologies, 43:13-14, 464-473
- 27. Manying Wang, Jixiang Ren, Xuenan Chen, Jianzeng Liu, Xiaohao Xu, Xiangyan Li, Daqing Zhao, Liwei Sun, 20(S)-ginsenoside Rg3 promotes myoblast differentiation and protects against myotube atrophy via regulation of the Akt/mTOR/FoxO3 pathway, Biochemical Ph
- 26. 王艳,尉忠贤,李晶.HPLC法测定不同厂家振源片中人参皂苷的含量[J].西北药学杂志,2020,35(05):669-673.
- 25. 邵紫君,李志满,于鹏程,陈建波,李珊珊,孙印石.氨基酸转化三七花中稀有人参皂苷及提取液对脂多糖诱导的RAW264.7细胞活性的影响[J].中草药,2021,52(03):702-710.
- 24. 张娜,黄鑫,郭云龙,越皓,刘淑莹.基于UPLC-QQQ-MS多指标统计分析研究不同生境人参中皂苷分布[J].特产研究,2020,42(06):48-54.
- 23. 温宝庆,李文庆,周妙霞,林坤霞,汪小东,钱正明.茯神饮中化学成分的核壳色谱-四级杆飞行时间质谱联用鉴定和分析[J].时珍国医国药,2020,31(06):1334-1338.
- 22. 李莉,周垚垚,李红艳,李海燕,张磊,岳洪水,李德坤,鞠爱春.HPLC法测定注射用益气复脉(冻干)中的4种低含量人参皂苷[J].药物评价研究,2020,43(08):1581-1586.
- 21. 吴冬雪,王秋颖,王淑敏,陈思键,刘淑莹,赵幻希,修洋.人参皂苷的仿生提取研究[J].分析试验室,2021,40(02):145-149.
- 20. 高松红,杨迪,李忠起,郑飞,JEON You-Jin,戴雨霖.快速高分辨液相色谱-质谱联用技术分析2型糖尿病大鼠口服四君子汤的药代动力学[J].应用化学,2021,38(03):315-322.
- 19. 杨林, 徐晓珍, 陈劲柏,等. UHPLC法同时测定参麦注射液中8种人参皂苷[J]. 中成药, 2019.
- 18. 徐灿辉, 何维为. 西洋参保健食品中7种人参皂苷的高效液相色谱法测定[J]. 食品与药品, 2015, 17(004):273-277.
- 17. 赵昶灵, 杨生超, 陈中坚,等. 紫,绿三七的总花色苷和总皂苷含量及皂苷单体组成[J]. 中药材, 2014, 37(10):1749-1753.
- 16. 苗瑞, 吴冬雪, 王秋颖,等. 基于多壁碳纳米管的人参皂苷快速分离[J]. 高等学校化学学报, 2018.
- 15. 张初瑜 陈素红 吴素香. 一测多评法测定复方人参片中的8种苷类成分[J]. 中国现代应用药学 2018 35(05):90-96.
- 14. 李晓青 田雅娟 杜娟 等. 一测多评法测定人参花中7种人参皂苷含量[J]. 中草药 2019 v.50;No.659(24):213-217.
- 13. 王京辉, 陈晶, 郭洪祝,等. 进口红参与国产红参皂苷类成分含量及鉴别成分研究[J]. 中国药学杂志, 2018, v.53(13):39-45.
- 12. 刘婷, 徐虹. 超高效液相色谱法快速测定参麦注射液中6种皂苷类成分含量[J]. 医药导报, 2016, 35(11):1259-1261.
- 11. 张富赓, 张瑜, 朱明丹,等. 芪苈强心胶囊中人参皂苷类成分在大鼠体内药动学研究[J]. 现代药物与临床, 2019(8):2268-2275.
- 10. 姜新刚, 贾继明, 李叶双,等. 芪苈强心胶囊UPLC指纹图谱研究[C]// 国际络病学大会. 2014.
- 9. 姜新刚, 贾继明, 李叶双. 津力达颗粒UPLC指纹图谱[J]. 中国实验方剂学杂志, 2013, 19(001):126-129.
- 8. 董坤园, 于澎, 熊金路,等. 基于高效液相色谱图谱结合化学计量学的红参指纹图谱研究[J]. 食品安全质量检测学报, 2019, 010(021):7316-7321.
- 7. 鲁辉, 吴杨, 闵春艳. 基于UPLC一测多评法测定西洋参及其保健食品中人参皂苷的含量[J]. 食品与药品, 2018, 020(003):173-179.
- 6. 何家乐,周思思,马增春,梁乾德,王宇光,谭洪玲,肖成荣,汤响林,高月.基于UPLC-Q-TOF/MS研究参附注射液的物质基础[J].中国药理学通报,2014,30(03):429-433.
- 5. 张艳欣, 朱国琴, 王丹丹. 均匀设计法优化林下山参中人参皂苷提取工艺的研究[J]. 上海医药, 2019, 040(015):89-92.
- 4. 郑威 江园园 于雪飞 等. 响应面优化匀浆提取人参总皂苷的工艺[J]. 食品工业 2019 40(02):32-36.
- 3. 魏可欣 郭云龙 史娜文 等. 人参药材等级标准[J]. 中国实验方剂学杂志 2019 025(011):145-153.
- 2. 闵春艳 张圆 吴杨 等. UPLC法结合PLS评价硫磺熏蒸对西洋参皂苷成分的影响[J]. 药物分析杂志 2018 038(003):432-442.
- 1. 李莉 周垚垚 李红艳 等. HPLC法测定注射用益气复脉(冻干)中的4种低含量人参皂苷[J]. 药物评价研究 2020.